Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin-139.8%-136pp-4.2%+4.6pp-8.9%+4.4pp-13.3%+6.8pp-20.1%+5.9pp
Net margin-140.2%-136pp-4.5%+4.3pp-8.8%+4.9pp-13.6%+6.7pp-20.4%+5.7pp
Returns
Return on equity-335.8%-327pp-8.6%+7.2pp-15.8%+8.4pp-24.2%+8.9pp-33.1%+4.0pp
Efficiency
Asset turnover0.7×0.0×0.7×0.0×0.6×0.0×0.6×+0.1×0.6×+0.1×
Liquidity
Current ratio2.1×-0.6×2.7×-0.6×3.3×+0.2×3.1×-0.1×3.2×+0.1×
Leverage
Debt-to-equity0.1×0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$4.12-34.3%$6.27+22.3%$5.12-0.1%$5.13+7.5%$4.77+0.5%
Valuation
Market capitalization$5.57B+36.5%$4.08B+10.8%$3.68B+45.5%$2.53B+14.7%$2.21B+11.2%
Price / sales9.8×+2.0×7.8×0.0×7.8×+1.9×5.9×+0.1×5.8×-0.1×
Price / book23×+10.0×13×+0.4×12.6×+2.7×9.9×+0.5×9.5×+0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Mirum Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Mirum Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.